Lantus Clinical Trials Lantus RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus
Condition:   Diabetes Mellitus Interventions:   Drug: Insulin Glargine Sansulin;   Drug: Insulin Glargine Pen Injector [Lantus] Sponsor:   Indonesia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials